Cargando…
Chemotherapy for hepatocellular carcinoma: The present and the future
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver. Its relationship to chronic liver diseases, in particular cirrhosis, develops on a background of viral hepatitis, excessive alcohol intake or metabolic steatohepatitis, leads to a high incidence and prevalence of this neop...
Autores principales: | Le Grazie, Marco, Biagini, Maria Rosa, Tarocchi, Mirko, Polvani, Simone, Galli, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545136/ https://www.ncbi.nlm.nih.gov/pubmed/28824742 http://dx.doi.org/10.4254/wjh.v9.i21.907 |
Ejemplares similares
-
PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO
por: Polvani, Simone, et al.
Publicado: (2012) -
Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation
por: Lami, Gabriele, et al.
Publicado: (2017) -
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma
por: Tarocchi, Mirko, et al.
Publicado: (2014) -
Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future
por: Ikeda, Masafumi, et al.
Publicado: (2015) -
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives
por: Rinninella, Emanuele, et al.
Publicado: (2017)